or
forgot password
  • cancer clinical trials in battle creek, MI

  • Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Prostate Cancer
    Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Carcinoma of Unknown Primary
    Dinaciclib in Treating Patients With Stage IV Melanoma
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Mucosal Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Lung Cancer
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Ovarian Cancer, Sarcoma
    Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Breast Cancer, Hot Flashes, Menopausal Symptoms, Unspecified Adult Solid Tumor, Protocol Specific
    Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Melanoma (Skin)
    Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Breast Cancer, Cardiac Toxicity
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Colorectal Cancer, Precancerous Condition
    Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Breast Cancer
    Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Breast Cancer
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Battle Creek Health System
    Battle Creek, Michigan 49017
    Breast Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Kidney Cancer
    Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Solar Radiation-related Skin Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Head and Neck Cancer, Mucositis, Oral Complications of Radiation Therapy, Pain
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Lymphoma
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Prostate Cancer
    Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Esophageal Cancer, Recurrent Gastric Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Breast Cancer, Depression, Fatigue, Sleep Disorders
    Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Head and Neck Cancer, Precancerous Condition
    S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Prostate Cancer
    S0820, Adenoma and Second Primary Prevention Trial
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    Colorectal Neoplasms
    S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Arthralgia, Breast Cancer, Pain
    Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Breast Cancer, Cancer Survivor, Hot Flashes
    Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Breast Cancer
    Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer
    Whole-Brain Radiation Therapy With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer, Tumors Metastatic to Brain
    SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Melanoma (Skin)
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Battle Creek Health System
    Battle Creek, Michigan 49017
    Anal Cancer
    S9912 Combination Chemo in Stage III Ovarian Cancer,
    Cancer Care Center at Battle Creek Health System
    Battle Creek, Michigan 49017
    Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Battle Creek Health System
    Battle Creek, Michigan 49017
    Breast Cancer
    S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
    S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma
    Battle Creek Health System
    Battle Creek, Michigan 49017
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Lung Cancer
    S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Leukemia, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Lung Cancer
    Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Lymphoma
    S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Leukemia
    S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Sarcoma
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Pancreatic Cancer
    S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Cancer Care Center at Battle Creek Health System
    Battle Creek, Michigan 49017
    Lung Cancer
    S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Esophageal Cancer
    S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Esophageal Cancer
    S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Head and Neck Cancer
    S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Melanoma (Skin)
    S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Esophageal Cancer
    Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Sarcoma
    S0515 Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Lymphoma
    S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Multiple Myeloma
    S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
    Battle Creek Health System Cancer Care Center
    Battle Creek, Michigan 49017
    Sarcoma
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Bronson Battle Creek
    Battle Creek, Michigan 49017
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer